Botanix Pharmaceuticals (ASX:BOT) Price-to-Operating-Cash-Flow : (As of Jun. 04, 2024)

View and export this data going back to 1985. Start your Free Trial

What is Botanix Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-06-04), Botanix Pharmaceuticals's share price is A$0.285. Botanix Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01. Hence, Botanix Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Botanix Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

ASX:BOT's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.44
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Botanix Pharmaceuticals's Cash Flow from Operations per share for the six months ended in Dec. 2023 was A$-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 19.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 17.20% per year.

During the past 13 years, Botanix Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 76.30% per year. The lowest was -75.40% per year. And the median was 28.60% per year.

Botanix Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Botanix Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Botanix Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Botanix Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Botanix Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Botanix Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Botanix Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Botanix Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Botanix Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Botanix Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Botanix Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Botanix Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.285	/	-0.008
	=

Botanix Pharmaceuticals's Share Price of today is A$0.285.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Botanix Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Botanix Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Botanix Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Botanix Pharmaceuticals (ASX:BOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (ASX:BOT) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BXPHF:USA

Address

661 Newcastle Street, D2, LEEDERVILLE, WA, AUS, 6007

Website

https://www.botanixpharma.com

Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals (ASX:BOT) Headlines

No Headlines